More so, significantly high levels of circulating CD5L has been reported in the patients suffering from pulmonary tuberculosis21, liver cirrhosis with HCV infection22, 23 and hepatocellular carcinoma with non-alcoholic fatty liver disease24. This evidence concerns the gene CD5L and cirrhosis of liver.